Latest News & Articles
Browse all our latest news articles and stories
FAQ: SenesTech's $2.3M Warrant Exercise and Its Implications
SenesTech, known for its EPA-registered rodent fertility control, has completed a $2.3M warrant exercise, issuing new warrants and purchasing shares …
August 27, 2024
Source
FAQ: SuperCom's Q2 and H1 2024 Earnings Growth and Record Profit
SuperCom (NASDAQ: SPCB) reports significant earnings growth and record profits in Q2 and H1 of 2024, driven by new orders and contracts for its …
August 27, 2024
Source
Lexaria Bioscience's DehydraTECH(TM) Technology and Its Impact on the Diabetes Treatment Market
Lexaria Bioscience has released findings from its research program evaluating the effectiveness of its DehydraTECH(TM) technology with the GLP-1 drug …
August 27, 2024
Source
Annovis Bio's New Patent for Buntanetap: Key Questions Answered
Annovis Bio (NYSE: ANVS) has filed a new composition of matter patent for buntanetap, a significant step in their research to combat neurodegenerative …
August 27, 2024
Source
D-Wave Quantum Optimization ROI Study and Technology Impact Awards Nomination FAQ
D-Wave Quantum Inc. (NYSE: QBTS) announced findings from a Hyperion Research study showing significant anticipated ROI from quantum optimization by …
August 27, 2024
Source
FAQ on SuperCom's New Juvenile Monitoring Contract in California
SuperCom Ltd. (NASDAQ: SPCB) has secured a contract to provide juvenile monitoring services in California through its subsidiary LCA, aiming to reduce …
August 27, 2024
Source
Clene's Submission of Briefing Book to FDA for CNM-Au8 in ALS Treatment
Clene plans to submit a briefing book to the FDA by July 13, 2024, as part of the process to seek approval for CNM-Au8 as a treatment for ALS, aiming …
August 27, 2024
Source
FAQ: SuperCom's New Contract for Juvenile Rehabilitative Services in California
SuperCom Ltd. (NASDAQ: SPCB) has secured a new contract through its subsidiary, Leaders in Community Alternatives (LCA), to provide rehabilitative …
August 27, 2024
Source
Annovis Bio's Phase III Study on Buntanetap for Early Parkinson’s Disease: Key FAQs
Annovis Bio announced positive results from its Phase III study of buntanetap for early Parkinson’s Disease, showing improvements in motor, cognitive, …
August 27, 2024
Source
FAQ on SuperCom's Latest $2.9M Government EM Contract and Its Impact
SuperCom Ltd. has secured a $2.9 million contract for its electronic monitoring technology from European governments, marking its third such contract …
August 27, 2024
Source
D-Wave's Latest Quantum Computing Advancements: Hybrid Solver and New U.S. Quantum Computer
D-Wave Quantum Inc. has announced the introduction of a new hybrid quantum solver and the deployment of a second U.S.-based Advantage quantum …
August 27, 2024
Source
Nutriband (NASDAQ: NTRB) Investor Webinar FAQ
Nutriband Inc. is hosting a live investor webinar on July 25, 2024, to discuss its transdermal technology developments and upcoming milestones, …
August 27, 2024
Source
FAQ: Mullen Automotive's Class 3 Electric Truck Purchase by Dublin, Ohio
Mullen Automotive has secured a purchase order from Dublin, Ohio, for its Class 3 electric truck, marking a significant step in the city's transition …
August 27, 2024
Source
FAQ on Clene's CNM-Au8(R) Updates and Its Impact on Neurodegenerative Disease Treatment
Clene Inc. (NASDAQ: CLNN) shared updates on CNM-Au8(R), a promising treatment for neurodegenerative diseases like ALS and MS, at the Emerging Growth …
August 27, 2024
Source
Annovis Bio's New Executive Team Members and Their Impact on Neurodegenerative Disease Therapies
Annovis Bio (NYSE: ANVS) has announced the addition of four seasoned professionals to its executive team, marking a pivotal step towards advancing its …
August 27, 2024
Source
FAQ on Mullen’s Subsidiary Warranty Coverage for Bollinger B4 Chassis Cab
Mullen Automotive's subsidiary, Bollinger Motors, has announced full warranty coverage for its all-electric Bollinger B4 Chassis Cab, highlighting the …
August 27, 2024
Source
FAQ on Scinai Immunotherapeutics' Anti-IL-17 NanoAb and PEI Feedback
Scinai Immunotherapeutics has received positive regulatory feedback from the Paul Erlich Institute (PEI) for its anti-IL-17A/F nanoAb (SCN-1) in …
August 27, 2024
Source
FAQ: Mullen Automotive's European Order for 29 Mullen GOs
Mullen Automotive has received a purchase order for 29 Mullen GOs, its commercial micro-urban-delivery vehicles, from GAMA, a European distributor, …
August 27, 2024
Source
FAQ on SenesTech’s Evolve(TM) and NYC’s Rat Problem
SenesTech’s Evolve(TM) offers a sustainable and humane solution to New York City’s rat problem, addressing criticisms of current methods like poisons …
August 27, 2024
Source